Facilitated By

San Antonio Medical Foundation

News

  • Angle PLC Announces HER2 Presentation at SABCS - BioSpace

    WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM. Independent findings support ANGLE's HER2 assay ...

  • Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK ... - ABC4 Utah

    ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium being held December 10-13, at ...

  • Machine learning model predicts breast cancer treatment response - Medical Xpress

    ... San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024. While the use of CDK4/6 inhibitors combined with endocrine therapy have ...

  • Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before ...

    Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast ...

  • Medicenna Presents Preclinical Data on MDNA11 as First Step to S - GuruFocus

    ... Biotechnology MDNAF. Medicenna Presents Preclinical Data on MDNA11 ... San Antonio Breast Cancer Symposium (SABCS), the world's largest breast ...